Physician profile
Robert Jerzy Krasowski
NPI 1346209699
$8,686.89
in general payments reported to CMS, 2019-2025
40 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,809 · 2020: $295 · 2021: $924 · 2022: $1,507 · 2023: $1,972 · 2024: $1,265 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,151.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $899.94 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $825.42 | 2019-2024 | Xarelto |
| Amgen INC. | $653.93 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $611.29 | 2021-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $610.27 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $546.29 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $416.90 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $415.93 | 2019-2025 | Farxiga |
| Irhythm Technologies, INC. | $391.18 | 2019-2024 | Zio Xt Patch, Zio Monitor, Zio At Patch |
| Esperion Therapeutics, INC. | $383.42 | 2021-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $355.53 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $327.30 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $324.76 | 2021-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.47 | 2019-2025 | Jardiance |
| Cvrx, INC. | $211.02 | 2019-2024 | Barostim Neo System |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $177.89 | 2023-2024 | Ffrct |
| Amarin Pharma, INC. | $168.31 | 2019-2022 | |
| Abbott Laboratories | $153.62 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $112.28 | 2019-2023 | Watchman Flx, Watchman Access System |
| Scpharmaceuticals INC. | $102.91 | 2024-2025 | |
| Lundbeck LLC | $90.87 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $72.83 | 2019-2022 | |
| Medtronic, INC. | $71.13 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $66.99 | 2019 | |
| Baxter Healthcare | $61.99 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $57.08 | 2024 | Inpefa |
| Gilead Sciences, INC. | $46.98 | 2019 | |
| Lilly USA, LLC | $39.62 | 2025 | Zepbound |
| Impulse Dynamics (USA) INC. | $29.79 | 2023 | Optimizer |
| Philips North America LLC | $27.71 | 2023 | |
| Kestra Medical Technology Services, INC. | $25.02 | 2024 | Assure Wcd |
| Kowa Pharmaceuticals America, INC. | $24.44 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $23.34 | 2019 | |
| Agepha Pharma Fz LLC | $22.44 | 2025 | Lodoco |
| Shield Therapeutics INC | $21.19 | 2023 | Accrufer |
| Vifor Pharma, INC. | $20.19 | 2022 | |
| Biotronik INC. | $18.10 | 2025 | Acticor 7 Vr-T Dx |
| Cashflow Solutions, LLC | $16.82 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Bardy Diagnostics, INC. | $15.00 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $14.70 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Krasowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.